B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Gdf11

257 PubMed studies analyzed · 1 RCTs · Evidence Score: 43

Research Domains

Gdf11 has been studied across 24 research domains including ⏳ Longevity & Aging, 💪 Strength & Power, 🔬 Oncology, 🔥 Metabolic, ❤️ Cardiovascular. The primary research focus is ⏳ Longevity & Aging with 22% of studies addressing this area.

Loading evidence profile...

This evidence profile for Gdf11 is generated deterministically from 257 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.